Patent: 10,434,195
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,434,195
Title: | Methylsulfonamide derivatives and uses related thereto |
Abstract: | This disclosure relates to methylsulfonamide derivatives and uses as imaging agents and other uses related to CXCR4 inhibition. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein, derivatives, or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for imaging to study CXCR4 related conditions. |
Inventor(s): | Shim; Hyunsuk (Atlanta, GA), Goodman; Mark M. (Atlanta, GA), Shetty; Dinesh (Atlanta, GA), Oum; Hyeun Yoon (Atlanta, GA) |
Assignee: | Emory University (Atlanta, GA) |
Application Number: | 15/750,086 |
Patent Claims: | see list of patent claims |
Details for Patent 10,434,195
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | See Plans and Pricing | 2035-08-03 |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | See Plans and Pricing | 2035-08-03 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | See Plans and Pricing | 2035-08-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |